» Articles » PMID: 23591487

Causes, Mechanisms and Management of Paediatric Osteoporosis

Overview
Specialty Rheumatology
Date 2013 Apr 18
PMID 23591487
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoporosis, a skeletal disorder characterized by compromised bone strength and an increased risk of fractures, is an important paediatric disorder that involves almost all paediatric subspecialties. Osteogenesis imperfecta is the most common form of childhood-onset primary osteoporosis, but several other forms are also known. Secondary osteoporosis is caused by an underlying chronic illness or its treatment. The most common causes of secondary osteoporosis include chronic systemic inflammation, glucocorticoid use and neuromuscular disabilities. The skeletal sequelae can present in childhood as low-energy peripheral and vertebral fractures, or become evident in adulthood as low bone mass and an increased propensity to develop osteoporosis. Management should aim at prevention, as interventions to treat symptomatic osteoporosis in the paediatric age group are scarce. Bisphosphonates are the principal pharmacological agents that can be used in this setting, but data on their efficacy and safety in paediatric populations remain inadequate, especially in patients with secondary osteoporosis. Consequently, it is important to understand the potential skeletal effects of paediatric illnesses and their therapies in order to institute effective and timely prevention of skeletal complications.

Citing Articles

The Association between Fluoride and Bone Mineral Density in US Children and Adolescents: A Pilot Study.

Kong H, He Z, Li H, Xing D, Lin J Nutrients. 2024; 16(17).

PMID: 39275266 PMC: 11397378. DOI: 10.3390/nu16172948.


Bone fragility and osteoporosis in children and young adults.

Formosa M, Christou M, Makitie O J Endocrinol Invest. 2023; 47(2):285-298.

PMID: 37668887 PMC: 10859323. DOI: 10.1007/s40618-023-02179-0.


The correlation between high-density lipoprotein cholesterol and bone mineral density in adolescents: a cross-sectional study.

Wang G, Li J, Liu D, Chu S, Li H, Zhao H Sci Rep. 2023; 13(1):5792.

PMID: 37031278 PMC: 10082797. DOI: 10.1038/s41598-023-32885-x.


Colles' Fracture: An Epidemiological Nationwide Study in Italy from 2001 to 2016.

Longo U, De Salvatore S, Mazzola A, Salvatore G, Mera B, Piergentili I Int J Environ Res Public Health. 2023; 20(5).

PMID: 36900966 PMC: 10002201. DOI: 10.3390/ijerph20053956.


Early-Onset Osteoporosis: Rare Monogenic Forms Elucidate the Complexity of Disease Pathogenesis Beyond Type I Collagen.

Costantini A, Makitie R, Hartmann M, Fratzl-Zelman N, Zillikens M, Kornak U J Bone Miner Res. 2022; 37(9):1623-1641.

PMID: 35949115 PMC: 9542053. DOI: 10.1002/jbmr.4668.


References
1.
Mayranpaa M, Viljakainen H, Toiviainen-Salo S, Kallio P, Makitie O . Impaired bone health and asymptomatic vertebral compressions in fracture-prone children: a case-control study. J Bone Miner Res. 2012; 27(6):1413-24. DOI: 10.1002/jbmr.1579. View

2.
Helenius I, Remes V, Salminen S, Valta H, Makitie O, Holmberg C . Incidence and predictors of fractures in children after solid organ transplantation: a 5-year prospective, population-based study. J Bone Miner Res. 2006; 21(3):380-7. DOI: 10.1359/JBMR.051107. View

3.
Bianchi M, Cimaz R, Galbiati E, Corona F, Cherubini R, Bardare M . Bone mass change during methotrexate treatment in patients with juvenile rheumatoid arthritis. Osteoporos Int. 1999; 10(1):20-5. DOI: 10.1007/s001980050189. View

4.
Takayanagi H . Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009; 5(12):667-76. DOI: 10.1038/nrrheum.2009.217. View

5.
Petty R, Southwood T, Manners P, Baum J, Glass D, Goldenberg J . International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31(2):390-2. View